{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:09:06Z","timestamp":1778206146328,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bleedings are frequent and dreaded complications in heart failure patients with ventricular assist devices (VAD). Serotonin reuptake inhibitor (SRI) antidepressants are widely used to treat depression in these patients, though they are attributed an increased risk of bleeding due to their modification of hemostasis. Evidence on bleeding risk of VAD patients under SRI medication is scarce and limited. We therefore aimed to assess if SRI use is associated with an elevated bleeding risk in this particularly vulnerable population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed the medical records of 92 VAD patients at the University Heart Center Zurich between September 2004 and April 2018 for the occurrence of bleedings and the concomitant use of an SRI. Bleeding was defined as any type of post-implantation bleeding requiring medical treatment. We performed univariate analyses and linear mixed-effects models, adjusting for baseline clinical characteristics as potential predictors to identify differences in bleeding rates in patients with vs. without SRI intake.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The cohort comprised 60.9% of patients with a continuous-flow VAD and 39.1% with a pulsatile-flow VAD. A total of 77.2% of patients experienced at least one bleeding incident. Overall, 28.6% of bleedings occurred under SRI therapy. A generalized linear mixed model showed a predictive effect of SRI medication on bleeding rate, independent of VAD type (<jats:italic>z<\/jats:italic>\u2009=\u20092.091, <jats:italic>p<\/jats:italic>\u2009=\u20090.037).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Bleeding events in heart failure patients occur frequently after VAD implantation. Patients with SRI medication were at increased risk of bleeding. The indication and use of SRI, therefore, should be considered carefully.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02557-1","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:03:35Z","timestamp":1647943415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-7364","authenticated-orcid":false,"given":"Bianca","family":"Auschra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8272-8414","authenticated-orcid":false,"given":"Markus J.","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Husung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4271-918X","authenticated-orcid":false,"given":"Josef","family":"Jenewein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-0630","authenticated-orcid":false,"given":"Andreas J.","family":"Flammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3037-8584","authenticated-orcid":false,"given":"Lena","family":"Jellestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"issue":"2","key":"2557_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.athoracsur.2018.11.011","volume":"107","author":"RL Kormos","year":"2019","unstructured":"Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships. Ann Thorac Surg. 2019;107(2):341\u201353.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"2557_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/HCO.0000000000000284","volume":"31","author":"A Koliopoulou","year":"2016","unstructured":"Koliopoulou A, McKellar SH, Rondina M, Selzman CH. Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets. Curr Opin Cardiol. 2016;31(3):299\u2013307.","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"2557_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","volume":"32","author":"D Feldman","year":"2013","unstructured":"Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157\u201387.","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"2557_CR4","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2006.06.055","volume":"48","author":"T Rutledge","year":"2006","unstructured":"Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527\u201337.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2557_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","volume":"40","author":"MJ Owens","year":"1994","unstructured":"Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem. 1994;40(2):288\u201395.","journal-title":"Clin Chem"},{"issue":"6","key":"2557_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.lfs.2004.04.060","volume":"76","author":"A Schins","year":"2004","unstructured":"Schins A, Hamulyak K, Scharpe S, Lousberg R, Van Melle J, Crijns H, et al. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci. 2004;76(6):637\u201350.","journal-title":"Life Sci"},{"issue":"20","key":"2557_CR7","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1001\/archinte.168.20.2232","volume":"168","author":"CM O'Connor","year":"2008","unstructured":"O\u2019Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med. 2008;168(20):2232\u20137.","journal-title":"Arch Intern Med"},{"issue":"1","key":"2557_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","volume":"9","author":"D Halperin","year":"2007","unstructured":"Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9(1):47\u201359.","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"2557_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/archinternmed.2007.32","volume":"168","author":"T Schalekamp","year":"2008","unstructured":"Schalekamp T, Klungel OH, Souverein PC, de Boer A. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med. 2008;168(2):180\u20135.","journal-title":"Arch Intern Med"},{"issue":"6","key":"2557_CR10","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3171\/2013.12.JNS131898","volume":"120","author":"P Lopponen","year":"2014","unstructured":"Lopponen P, Tetri S, Juvela S, Huhtakangas J, Saloheimo P, Bode MK, et al. Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: a population-based study. J Neurosurg. 2014;120(6):1358\u201363.","journal-title":"J Neurosurg"},{"issue":"16","key":"2557_CR11","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1503\/cmaj.100912","volume":"183","author":"C Labos","year":"2011","unstructured":"Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ. 2011;183(16):1835\u201343.","journal-title":"CMAJ"},{"issue":"6","key":"2557_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/0267659118765933","volume":"33","author":"MJ Eckersley","year":"2018","unstructured":"Eckersley MJ, Sepehripour AH, Casula R, Punjabi P, Athanasiou T. Do selective serotonin reuptake inhibitors increase the risk of bleeding or mortality following coronary artery bypass graft surgery? A meta-analysis of observational studies. Perfusion. 2018;33(6):415\u201322.","journal-title":"Perfusion"},{"key":"2557_CR13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.hlc.2019.07.011","volume":"29","author":"G Mawardi","year":"2019","unstructured":"Mawardi G, Markman TM, Muslem R, Sobhanian M, Converse M, Meadows HB, et al. SSRI\/SNRI therapy is associated with a higher risk of gastrointestinal bleeding in LVAD patients. Heart Lung Circul. 2019;29:1241.","journal-title":"Heart Lung Circul"},{"issue":"6","key":"2557_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.healun.2015.12.025","volume":"35","author":"J Schultz","year":"2016","unstructured":"Schultz J, Bream-Rouwenhorst H, Hobbs R, McDanel D, Goerbig-Campbell J. Serotonergic agents increase the incidence of gastrointestinal bleeds in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2016;35(6):823\u20134.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2557_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.gie.2014.03.040","volume":"80","author":"KV Draper","year":"2014","unstructured":"Draper KV, Huang RJ, Gerson LB. GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. Gastrointest Endosc. 2014;80(3):435-46.e1.","journal-title":"Gastrointest Endosc"},{"key":"2557_CR16","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing V, Austria. 2018. https:\/\/www.R-project.org\/."},{"key":"2557_CR17","doi-asserted-by":"crossref","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. 2015;67(1):48.","DOI":"10.18637\/jss.v067.i01"},{"issue":"2","key":"2557_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1060028018794005","volume":"53","author":"AL Bixby","year":"2019","unstructured":"Bixby AL, VandenBerg A, Bostwick JR. Clinical management of bleeding risk with antidepressants. Ann Pharmacother. 2019;53(2):186\u201394.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2557_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.psc.2016.04.010","volume":"39","author":"C Andrade","year":"2016","unstructured":"Andrade C, Sharma E. Serotonin reuptake inhibitors and risk of abnormal bleeding. Psychiatr Clin North Am. 2016;39(3):413\u201326.","journal-title":"Psychiatr Clin North Am"},{"key":"2557_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jad.2017.08.002","volume":"225","author":"KS Na","year":"2018","unstructured":"Na KS, Jung HY, Cho SJ, Cho SE. Can we recommend mirtazapine and bupropion for patients at risk for bleeding? A systematic review and meta-analysis. J Affect Disord. 2018;225:221\u20136.","journal-title":"J Affect Disord"},{"issue":"4","key":"2557_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.hlc.2011.12.002","volume":"21","author":"PJ Tully","year":"2012","unstructured":"Tully PJ, Cardinal T, Bennetts JS, Baker RA. Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery. Heart Lung Circ. 2012;21(4):206\u201314.","journal-title":"Heart Lung Circ"},{"issue":"10","key":"2557_CR22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.amjcard.2009.01.348","volume":"103","author":"DH Kim","year":"2009","unstructured":"Kim DH, Daskalakis C, Whellan DJ, Whitman IR, Hohmann S, Medvedev S, et al. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol. 2009;103(10):1391\u20135.","journal-title":"Am J Cardiol"},{"issue":"6","key":"2557_CR23","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1213\/ANE.0000000000002668","volume":"126","author":"MM Smith","year":"2018","unstructured":"Smith MM, Smith BB, Lahr BD, Nuttall GA, Mauermann WJ, Weister TJ, et al. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are not associated with bleeding or transfusion in cardiac surgical patients. Anesth Analg. 2018;126(6):1859\u201366.","journal-title":"Anesth Analg"},{"issue":"1","key":"2557_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/17425255.2020.1700952","volume":"16","author":"E Spina","year":"2020","unstructured":"Spina E, Barbieri MA, Cicala G, Bruno A, de Leon J. Clinically relevant drug interactions between newer antidepressants and oral anticoagulants. Expert Opin Drug Metab Toxicol. 2020;16(1):31\u201344.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"2557_CR25","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.cgh.2009.08.019","volume":"7","author":"M Dall","year":"2009","unstructured":"Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2009;7(12):1314\u201321.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2557_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jtcvs.2008.07.032","volume":"137","author":"S Crow","year":"2009","unstructured":"Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;137(1):208\u201315.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"2557_CR27","first-page":"573","volume":"3","author":"A Cheng","year":"2014","unstructured":"Cheng A, Williamitis CA, Slaughter MS. Comparison of continuous-flow and pulsatile-flow left ventricular assist devices: is there an advantage to pulsatility? Ann Cardiothoracic Surg. 2014;3(6):573\u201381.","journal-title":"Ann Cardiothoracic Surg"},{"issue":"4","key":"2557_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.healun.2014.09.042","volume":"34","author":"ME Nassif","year":"2015","unstructured":"Nassif ME, Tibrewala A, Raymer DS, Andruska A, Novak E, Vader JM, et al. Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke. J Heart Lung Transplant. 2015;34(4):503\u20138.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"2557_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","volume":"33","author":"SS Najjar","year":"2014","unstructured":"Najjar SS, Slaughter MS, Pagani FD, Starling RC, McGee EC, Eckman P, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33(1):23\u201334.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"2557_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-015-0618-1","volume":"18","author":"JZ Willey","year":"2016","unstructured":"Willey JZ, Boehme AK, Castagna F, Yuzefpolskaya M, Garan AR, Topkara V, et al. Hypertension and stroke in patients with left ventricular assist devices (LVADs). Curr Hypertens Rep. 2016;18(2):12.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"2557_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/CIRCHEARTFAILURE.114.002000","volume":"8","author":"O Saeed","year":"2015","unstructured":"Saeed O, Jermyn R, Kargoli F, Madan S, Mannem S, Gunda S, et al. Blood pressure and adverse events during continuous flow left ventricular assist device support. Circ Heart Fail. 2015;8(3):551\u20136.","journal-title":"Circ Heart Fail"},{"issue":"11","key":"2557_CR32","doi-asserted-by":"publisher","first-page":"e005267","DOI":"10.1161\/CIRCHEARTFAILURE.118.005267","volume":"11","author":"MY Yin","year":"2018","unstructured":"Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, et al. Novel model to predict gastrointestinal bleeding during left ventricular assist device support. Circ Heart Fail. 2018;11(11):e005267.","journal-title":"Circ Heart Fail"},{"issue":"5","key":"2557_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1053\/j.ackd.2018.08.004","volume":"25","author":"C Ronco","year":"2018","unstructured":"Ronco C, Bellasi A, Di Lullo L. Cardiorenal syndrome: an overview. Adv Chronic Kidney Dis. 2018;25(5):382\u201390.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"2557_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","volume":"13","author":"JT Heywood","year":"2007","unstructured":"Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Cardiac Fail. 2007;13(6):422\u201330.","journal-title":"J Cardiac Fail"},{"issue":"3","key":"2557_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.amjcard.2006.08.042","volume":"99","author":"A Ahmed","year":"2007","unstructured":"Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol. 2007;99(3):393\u20138.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2557_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ndt\/gfn445","volume":"24","author":"RC Campbell","year":"2009","unstructured":"Campbell RC, Sui X, Filippatos G, Love TE, Wahle C, Sanders PW, et al. Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study. Nephrol Dial Transplant. 2009;24(1):186\u201393.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2557_CR37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.athoracsur.2020.12.038","volume":"111","author":"EJ Molina","year":"2021","unstructured":"Molina EJ, Shah P, Kiernan MS, Cornwell WK 3rd, Copeland H, Takeda K, et al. The Society of Thoracic Surgeons Intermacs 2020 Annual report. Ann Thorac Surg. 2021;111(3):778\u201392.","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"2557_CR38","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1111\/bcp.13660","volume":"84","author":"M Iwagami","year":"2018","unstructured":"Iwagami M, Tomlinson LA, Mansfield KE, Douglas IJ, Smeeth L, Nitsch D. Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: a population-based cohort study. Br J Clin Pharmacol. 2018;84(9):2142\u201351.","journal-title":"Br J Clin Pharmacol"},{"key":"2557_CR39","unstructured":"Eager C, Roy J. Mixed effects models are sometimes terrible. 2017."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02557-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:06:36Z","timestamp":1647943596000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02557-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2557"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02557-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"5 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients gave written informed consent for the use of their health-related data for research, or, if already deceased, who did not have a documented disapproval to use health-related data for research. All The study was approved by the national ethics committee Zurich (project ID 2018-00427) and was carried out in accordance with the Good Clinical Practice standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.J.W. declares speaker\u2019s honoraria and travel expenses from Berlin Heart with relevance to this article. A.J.F. declares research support from Berlin Heart and fees from Medtronic relevant to this article, as well as fees from Alnylam, Amgen, AstraZeneca, Fresenius, Imedos Systems, Novartis, Pfizer, Roche, Vifor, and Zoll, unrelated to this article. All other authors reported no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}